Advertisement

Latest News

Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight

2 hours ago

Diabetes Dialogue cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, cover topline data from the TRIUMPH-1 trial of retatrutide for obesity management.

Endotyping & Biomarkers in CSU, With Jonathan Bernstein, MD

17 hours ago

Bernstein discussed the evolving role of biomarkers in chronic spontaneous urticaria at EAC 2026.

Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA

19 hours ago

This interview highlights topline findings from Part B of the phase 2 APEX trial highlight the efficacy of zumilokibart (APG777) in adults with atopic dermatitis.

Could E2F2 Offer a More Precise Anti-Remodeling Target in PAH?

21 hours ago

In this Q&A, Tatiana V. Kudryashova, PhD, discusses new data presented at ATS 2026 that show silencing E2F2 suppresses hyperproliferation in PAH smooth muscle cells.

Bepirovirsen Achieves 19% Functional Cure in Chronic Hepatitis B

23 hours ago

Pooled B-Well phase 3 data show bepirovirsen achieved a 19% functional cure rate in CHB vs 0% with standard of care alone.

Advertisement
Advertisement